Unravelling Chlamydia trachomatis diversity in Amhara, Ethiopia: MLVA-ompA sequencing as a molecular typing tool for trachoma.
Trachoma is the leading infectious cause of blindness worldwide and is now largely confined to around 40 low- and middle-income countries. It is caused by Chlamydia trachomatis (Ct), a contagious intracellular bacterium. The World Health Organization recommends mass drug administration (MDA) with az...
Saved in:
Main Authors: | Anna J Harte (Author), Ehsan Ghasemian (Author), Harry Pickering (Author), Joanna Houghton (Author), Ambahun Chernet (Author), Eshetu Sata (Author), Gizachew Yismaw (Author), Taye Zeru (Author), Zerihun Tadesse (Author), E Kelly Callahan (Author), Scott D Nash (Author), Martin J Holland (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlamydia trachomatis ompA variants in trachoma: what do they tell us?
by: Aura A Andreasen, et al.
Published: (2008) -
Wait and watch: A trachoma surveillance strategy from Amhara region, Ethiopia.
by: Eshetu Sata, et al.
Published: (2024) -
Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma.
by: Arman Mosenia, et al.
Published: (2022) -
Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia.
by: Scott D Nash, et al.
Published: (2020) -
Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
by: Tigist Astale, et al.
Published: (2018)